Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 5Phase 1/2 4Phase NA 3Phase 3 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 3Terminated 1Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 1Myeloid 1Lymphoid 1Head & Neck 1Genitourinary 1CNS 1Breast 1

Conditions

Breast Neoplasms 523Leukemia, Myeloid, Acute 499Neoplasms 381Carcinoma, Non-Small-Cell Lung 381Pancreatic Neoplasms 329Precursor Cell Lymphoblastic Leukemia-Lymphoma 319Multiple Myeloma 312Glioblastoma 311Melanoma 309Prostatic Neoplasms 293Leukemia 289Neoplasm Metastasis 284Brain Neoplasms 276Lymphoma 271Lung Neoplasms 270Recurrence 266Ovarian Neoplasms 247Colorectal Neoplasms 246Lymphoma, Non-Hodgkin 242Leukemia, Lymphocytic, Chronic, B-Cell 231Myelodysplastic Syndromes 208Glioma 208Lymphoma, Large B-Cell, Diffuse 186Carcinoma, Hepatocellular 173Lymphoma, Follicular 167Head and Neck Neoplasms 162Hodgkin Disease 160Lymphoma, Mantle-Cell 155Burkitt Lymphoma 154Sarcoma 150

Interventions

Sirolimus 2temsirolimus 1saracatinib 1Valproic Acid 1Immunoglobulin G 1Imatinib Mesylate 1Hydroxychloroquine 1Glutamine 1Disulfides 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Lymphangioleiomyomatosis × Clear all
NCT01552434 2026-05-15

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
154 enrolled
BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

NCT06889168 2026-01-21

LAMP-2

Columbia University

Phase 1 Recruiting
20 enrolled

Lymphangioleiomyomatosis

NCT04388371 2021-08-11

Glutamine PET Imaging in LAM

Vanderbilt University Medical Center

Phase 1 Completed
5 enrolled

Lymphangioleiomyomatosis

NCT01687179 2018-10-11

SAIL

Brigham and Women's Hospital

Phase 1 Completed
14 enrolled 14 charts

Lymphangioleiomyomatosis

NCT02116712 2016-11-30

The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)

Baylor College of Medicine

Phase 1 Completed
9 enrolled

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡